评估严重的宁-氨-阿尔多素系统抑制剂诱导的血管风险因素
Govind Bindra1, Debendra Pattanaik2, Anthony Sheyn3,4,5
1University of Tennessee Health Science Center, Memphis, Tennessee, USA.
The Laryngoscope
|December 8, 2025
概括
鉴定氨酸- ангиотензин- алдостерон系统抑制剂 (RAASi) 诱导的血管风的危险因素对于患者分组至关重要. 喉胀是这些患者不良结果的强有力的预测因素.
科学领域:
- 紧急医疗 紧急医疗
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
背景情况:
- 列宁- ангиотензин- алдостерон系统抑制剂 (RAASi) 可以导致血管,这是一种可能危及生命的疾病.
- 在急诊室 (ED) 中对RAASi诱导的血管患者进行有效的分组对于最佳的患者结果至关重要.
研究的目的:
- 确定患有RAASi诱导的血管的患者入院,重症监护室 (ICU) 入院和输管治疗的风险因素.
- 评估特定临床发现的预测价值,例如喉和舌头胀,对不良结果.
主要方法:
- 2006年至2016年期间访问ED的RAASi诱导的血管成年患者的回顾性队列研究.
- 收集的数据包括人口统计,症状,并发症,药物史,输管细节和不良事件.
- 分析了光纤检查结果与临床结果的关联.
主要成果:
- 喉胀 (OR 133.79) 和前舌胀 (OR 4.15) 是包括输管治疗在内的不良结果的重要预测因素.
- 33%的患者需要接受ICU治疗,16.2%需要输管治疗.
- 结合喉胀,前舌胀和BMI的模型显示出出色的预测性能.
结论:
- 光纤检查是评估RAASi诱导的ED血管的严重程度的一个有价值的工具.
- 关键的临床因素,包括喉和舌头胀,可以有效地识别患有严重并发症高风险的患者,有助于分拣和管理.
相关概念视频
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.2K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.2K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
888
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
888
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.4K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K
01:33Hormonal Regulation
35.6K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.6K
01:26Nephrotic Syndrome II : Assessment and Medical Management
184
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
184